SI
SI
discoversearch

Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
476 12 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

neptunecorp.com

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST

acastipharma.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
476Cannabidiol (CBD) There is increased interest from Member States in the use of Sultan-Monday
475This is 4 years old interview but it gives you an idea as to why Mr. Haywood'Sultan-Sunday
474Haywood George Weaver fintel.ioSultan-last Friday
473Acasti Pharma has 194% upside, Echelon Wealth says cantechletter.com Note: AnaSultan-last Friday
472Couple of interesting Insiders transactions in January.. Richard Paul SchottenSultan-last Friday
471CC Transcript Just couple of extracts here.. If you are share holder, check thSultan1last Wednesday
470Earning CC Slides seekingalpha.comSultan-last Wednesday
469Neptune Announces Third Quarter Results finance.yahoo.comSultan-last Wednesday
468ACASTI PHARMA PRESENTS AT BIOTECH SHOWCASE CONFERENCE, JANUARY 2018 acastipharmSultan-February 13
467Neptune Institutional Ownership fintel.ioSultan-February 13
466Acasti 13/Gstocknewsflow.comSultan-February 13
465Acasti Pharma Reports Third Quarter FY 2018 Financial Results LAVAL, QUEBEC--(MSultan-February 13
464Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified CannabiSultan-February 12
463CBD Summit covers cannabis from seed to shelf—and then some newhope.comSultan-February 8
462Acasti Pharma (Nasdaq/ACST) dawsonjames.comSultan-February 3
461Neptune to Hold Conference Call to Discuss Third Quarter Results for the InterimSultan-January 31
460[tweet]Sultan-January 30
459 Think sepsis to stop deaths, urge advocates cmaj.caSultan-January 28
458January Presentation neptunecorp.comSultan-January 28
457CanniMed has also demonstrated success in developing and monetizing value-added Sultan1January 24
456 Neptune to partner in researching krill oil as CBD carrier, bioavailability enhSultan-January 23
455Acasti Pharma Announces the Closing of Over-Allotment Option for its Public OffeSultan-January 23
454Neptune Announces Research Agreement Aimed at New Medical and Wellness CannabinoSultan-January 19
453Neptune makes its recommendations on Bill 157 special consultations at the NatioSultan-January 17
452Alex Ruus, Portfolio Manager, Arrow Capital Managment discussing ACST at 6.35 maSultan-January 17
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.